国际生物制品学杂志
國際生物製品學雜誌
국제생물제품학잡지
INTERNATIONAL JOURNAL OF BIOLOGICALS
2012年
4期
175-177
,共3页
王琰%肖亮明%杨佳平%李晓军%王树巧
王琰%肖亮明%楊佳平%李曉軍%王樹巧
왕염%초량명%양가평%리효군%왕수교
卡介苗%工作种子批%安全性%接种
卡介苗%工作種子批%安全性%接種
잡개묘%공작충자비%안전성%접충
BCG vaccine%Working seed lot%Safety%Vaccination
目的 对两个工作种子批菌种D2-甲12制备的两批冻干卡介苗接种人体后的安全性和效果进行临床考核.方法 对100名结核杆菌纯化蛋白衍生物(PPD)皮肤试验阴性的3月龄~50岁健康对象和205名新生儿分别接种上述两个批次的观察疫苗和一个对照疫苗.观察接种后的局部和全身反应,测量卡痕,并对新生儿进行PPD皮肤试验.采用x2检验和t检验对新生儿各组间的卡痕和PPD试验结果进行比较.结果 所有对象接种后均未发现接种部位和全身不良反应.新生儿卡痕均值≥4.6 mm,PPD硬结均值≥6.8 mm.卡痕和PPD试验阳性率均超过90%,两者在新生儿各组间的差异均无统计学意义(x2=0.001~1.713,P=0.191~1.000).卡痕均值和PPD硬结均值在两个观察疫苗组间的差异无统计学意义(t=0.773,P=0.441;t=0.226,P=0.822),而对照疫苗组与两个观察疫苗组间的差异均有统计学意义(t =2.645~3.361,P =0.001~0.010).结论 两个工作种子批菌种D2-甲12制备的卡介苗接种人体是安全的,并具有良好的接种效果.
目的 對兩箇工作種子批菌種D2-甲12製備的兩批凍榦卡介苗接種人體後的安全性和效果進行臨床攷覈.方法 對100名結覈桿菌純化蛋白衍生物(PPD)皮膚試驗陰性的3月齡~50歲健康對象和205名新生兒分彆接種上述兩箇批次的觀察疫苗和一箇對照疫苗.觀察接種後的跼部和全身反應,測量卡痕,併對新生兒進行PPD皮膚試驗.採用x2檢驗和t檢驗對新生兒各組間的卡痕和PPD試驗結果進行比較.結果 所有對象接種後均未髮現接種部位和全身不良反應.新生兒卡痕均值≥4.6 mm,PPD硬結均值≥6.8 mm.卡痕和PPD試驗暘性率均超過90%,兩者在新生兒各組間的差異均無統計學意義(x2=0.001~1.713,P=0.191~1.000).卡痕均值和PPD硬結均值在兩箇觀察疫苗組間的差異無統計學意義(t=0.773,P=0.441;t=0.226,P=0.822),而對照疫苗組與兩箇觀察疫苗組間的差異均有統計學意義(t =2.645~3.361,P =0.001~0.010).結論 兩箇工作種子批菌種D2-甲12製備的卡介苗接種人體是安全的,併具有良好的接種效果.
목적 대량개공작충자비균충D2-갑12제비적량비동간잡개묘접충인체후적안전성화효과진행림상고핵.방법 대100명결핵간균순화단백연생물(PPD)피부시험음성적3월령~50세건강대상화205명신생인분별접충상술량개비차적관찰역묘화일개대조역묘.관찰접충후적국부화전신반응,측량잡흔,병대신생인진행PPD피부시험.채용x2검험화t검험대신생인각조간적잡흔화PPD시험결과진행비교.결과 소유대상접충후균미발현접충부위화전신불량반응.신생인잡흔균치≥4.6 mm,PPD경결균치≥6.8 mm.잡흔화PPD시험양성솔균초과90%,량자재신생인각조간적차이균무통계학의의(x2=0.001~1.713,P=0.191~1.000).잡흔균치화PPD경결균치재량개관찰역묘조간적차이무통계학의의(t=0.773,P=0.441;t=0.226,P=0.822),이대조역묘조여량개관찰역묘조간적차이균유통계학의의(t =2.645~3.361,P =0.001~0.010).결론 량개공작충자비균충D2-갑12제비적잡개묘접충인체시안전적,병구유량호적접충효과.
Objective To investigate safety and immune effect of lyophilized BCG vaccines produced by 2 working seed lots in a clinical trial.Methods One hundred healthy subjects aged 3 months to 50 years old with negative purified protein derivative (PPD) skin test and 205 neonates were immunized with the 2 test vaccines and a control vaccine.Local and systemic reactions were investigated and BCG scar size was measured.PPD skin test was performed in the neonatal infants.x2 and t tests were adopted for comparison of BCG scar sizes and PPD test results among 3 neonatal groups.Results No local or systemic adverse reactionswere observed in all subjects.In the neonates,the average diameters of BCG scar and PPD induration were ≥4.6 mm and ≥6.8 mm,respectively.Both the positive rates of BCG scar and PPD test were >90%.No statistically significant differences in the positive rates of BCG scar and PPD test were found among 3 neonatal groups (x2 =0.001 ~ 1.713,P =0.191 ~ 1.000).The average diameters of BCG scar and PPD induration were no significantly different between 2 test vaccine groups (t =0.773,P =0.441 ; t =0.226,P =0.822),but the statistical differences were observed between the control group and 2 test groups (t =2.645 ~ 3.361,P=0.001~0.010).Conclusion The lyophilized BCG vaccines prepared by two working seed lots are proved to be safe and immunologically effective for human immunization.